Interplay Between Inflammation and Epigenetic Changes in Cancer.

Area of Science:

• Oncology
• Immunology
• Epigenetics

Background:

• Immune responses have a dual role in cancer, potentially suppressing or promoting tumor growth.
• Epigenetic alterations, like DNA methylation, are crucial in carcinogenesis by affecting gene expression.
• Chronic inflammation can induce cancer-specific epigenetic changes in epithelial cells.

Purpose of the Study:

• To explore the complex interplay between inflammation and epigenetics in cancer.
• To detail how these interactions contribute to tumor initiation, promotion, and immune evasion.
• To highlight the therapeutic potential of targeting inflammation-epigenetic links in cancer treatment.

Main Methods:

• Review of existing literature on immunology, epigenetics, and cancer biology.
• Analysis of mechanisms linking inflammation-induced epigenetic changes to carcinogenesis.
• Examination of how cancer cells use epigenetic silencing to evade immune surveillance.

Main Results:

• Inflammation can drive epigenetic alterations in epithelial cells, mirroring changes seen in cancer.
• Epigenetic modifications are integral to immune cell differentiation and inflammatory responses.
• Cancer cells exploit epigenetic mechanisms to suppress anti-tumor immunity.

Conclusions:

• The intricate relationship between inflammation and epigenetics is fundamental to cancer initiation and progression.
• Targeting the convergence of inflammation and epigenetic dysregulation presents promising strategies for cancer prevention and therapy.